Mr. McCoy, Civica’s COO, will succeed Martin VanTrieste at the helm, effective June 1, according to a news release. Mr. VanTrieste, who came out of retirement four years ago to lead Civica, will continue serving on the company’s board.
The leadership transition comes as Civica is building a drug manufacturing facility in Petersburg, Va., which is expected to be operational in early 2024. In March, the company also announced plans to manufacture and distribute three insulins at a discounted price.
Before joining Civica, Mr. McCoy worked at Abbott for more than three decades, according to the release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
